Latest Aragon Pharmaceuticals Inc. Stories
SAN DIEGO, Aug.
SAN DIEGO, April 22 /PRNewswire/ -- Aragon Pharmaceuticals Inc. today announced that it has secured $22 million in Series B financing. New investor Aisling Capital participated in the financing along with existing investors OrbiMed Advisors and The Column Group.
- Withering but not falling off, as a blossom that persists on a twig after flowering.